Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts


About Conference

ConferenceSeries llc LTD invites all the participants from all over the world to attend ‘International Conference on Organ Donation and Transplantation Science' during July 14-15, 2019 Sydney, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Transplantation Science 2019 is the premier event that brings together a unique and international mix of experts, researchers and decision makers both from academia, medical and hospitals across the globe to exchange their knowledge, expertise and research innovations to build world class expert Doctors.
It’s our greatest pleasure to welcome you to the official website of ‘International Conference on Organ Donation and Transplantation Science’ that aims at bringing together the Professors, Researchers, Doctors, and Surgeons to provide an international forum for the dissemination of original research results, new ideas and practical development experiences which concentrate on both theory and practices. The conference will be held in April 11-12, 2019 Wellington, New Zealand. The theme of the conference is “Frontiers in Transplantation Science for Promising Future”. Featuring 2-days of scientific workshop, special sessions, speaker & poster session, Industrial Expo. 300+ attendees from all over the world.
The event focuses on aspects such as Organ Transplantation Surgery, Heart Transplant Surgery, Liver Transplantation, Kidney Transplantation, Lungs Transplantation, Gender reassignment Surgery and Transplantation Techniques as well understanding tools to overcome barrier and enable successful data analysis and management. Conference Series llc Ltd organizes of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend???
With members from around the world focused on learning about Organ Transplantation and its advances; this is your best opportunity to reach the largest assemblage of participants from the Organ Donation and Transplantation Science community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new advancements and developments, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Organ Transplantation are hallmarks of this conference.
Why Wellington, New Zealand?
The capital of New Zealand, Wellington is surrounded by hills and a rugged coastline, and boasts a stunning harbour. Wellington's charm is that it serves up a vibrant inner city experience with a slice of New Zealand scenery. The population is approximately 370,000. Wellington is also a cultural center—home to Te Papa, the ground-breaking interactive Museum of New Zealand, the New Zealand Symphony Orchestra and national treasures such as the original Treaty of Waitangi and Katherine Mansfield's Birthplace. The city is compact and interesting, nestled between a dramatic harbour and bush clad hills. Great views can be found at the top of Mount Victoria, or by catching the cable car up to the Botanic Gardens. Downtown Wellington is ideally explored on foot. Made up of four quarters each with their own distinct mix of shopping, cafes, transport, accommodation, Wellington's intense urban experience is unrivalled in the country. The central city area of Wellington is the place to see performing arts, particularly ballet, theatre and musical performances. Local cuisine is sophisticated and inventive—an abundance of excellent cafes and restaurants are within walking distance of all the major hotels. The waterfront has been transformed into a graceful promenade with shops, restaurants, activities and elegant landscaping making it a real draw card for visitors and locals alike. The new state of the art sports and entertainment stadium is just a short walk from downtown.
Thankfully, Air travelers won’t need to go out of their way to experience the multitude of shopping, dining and entertainment experiences on offer at the Airport’s.
Target Audience:
  • Heart surgeons
  • Scientists
  • Researchers
  • Expert Surgeons
  • Doctors
  • Dermatologists
  • Organ Transplantation Associations
  • Organ Transplantation Societies
  • Business Entrepreneurs
  • Training Institutes
  •  Hospitals
  • Manufacturing Medical Devices Companies
 For more information:


Organ Transplantation Surgery is a beneficial technique in which a section of tissue or a complete organ that is removed from its original natural site and transferred to a new position in the same person or in a separate individual. The donated organ may be from a deceased donor, a living donor. In some cases an artificial organ are also used.

WHO Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)

Track 2 Organ Donations:

Organ donation is an act of giving one or more organs without compensation for transplantation into someone else. Organ donation is a very personal yet complex decision, intertwined with medical, legal, religious, cultural, and ethical issues. Donations include the liver, kidney, pancreas, and heart.
Liver transplant is a surgical procedure to remove a diseased liver and replace it with a healthy liver from a donor. Most liver transplant operations use livers from deceased donors, though a liver may also come from a living donor. The liver has sizable reserves and a great capacity to regenerate itself. Often, symptoms aren't evident until significant damage has been done. At present, there is no known way to medically compensate for the loss of a liver.
Kidney transplant is a treatment for persons who have chronic renal failure requiring dialysis. Kidney transplants are among the most commonly performed types of transplant surgery. Kidneys often are donated from living relatives to ensure the greatest prospects of long-term survival and today, more than four-fifths of patients with transplanted kidneys will survive for more than five years.
Heart transplantation is the replacement of a patient's diseased or injured heart with a healthy donor heart. Heart Transplantation is a treatment option for people who are in the end stages of heart failure. Heart transplant surgery lasts for approximately four hours. During that time, you’ll be placed on a heart-lung machine to keep blood circulating throughout your body.
Robotic Transplantation is a robot-assisted surgery that aids surgeons in executing the most complex operations with extreme accuracy, mobility, and control as compared to the traditional procedures. The most widely used clinical robotic surgical system includes a camera arm and mechanical arms with surgical instruments attached to them. The surgeon controls the arms while seated at a computer console near the operating table. The console gives the surgeon a high-definition, magnified, 3-D view of the surgical site.
The Medical device industry makes an enormous number of products ranging from surgical gloves to artificial joints to imaging equipment and plays a crucial role in developing new medical technologies that can improve the ability to diagnose and treat illness. The industry has a relatively small number of large, diversified companies and a large number of smaller companies that are mainly engaged in research and development of new devices for specific therapeutic areas. The industry is distinctive both for its tendencies to make frequent, incremental changes to its products and its extensive ties with physicians.
Gender reassignment surgery, sometimes called Sex reassignment surgery, is implemented to transition individuals with gender dysphonia to their desired gender. Gender reassignment is irrelevant to a person’s ability to perform a job. Indeed, having previously had to live with the pressure of gender dysphoria, a transsexual person who has completed a change of gender identity is likely to emerge a better worker than before.
In Transplantation technique a complete organ that is removed from its original natural site and transferred to a new position in the same person or in a separate individual. The term, like the synonym graft, was borrowed from horticulture. Both words imply that success will result in a healthy and flourishing graft or transplant, which will gain its nourishment from its new environment.
A bone marrow transplant involves taking cells that are normally found in the bone marrow, filtering those cells, and giving them back either to the patient they were taken from or to another person. The goal of BMT is to transfuse healthy bone marrow cells into a person after his or her own unhealthy bone marrow has been eliminated.
This involves the removal of healthy skin tissues from one part of the body and transplanting it to the burn site. This skin graft may include only a few outer layers of skin or may involve the entire dermis. This is used in cases of severe burns where a large section of the dermis is affected. This procedure has many advantages as the skin colour and texture are a near perfect match thus reducing scarring to a large extent.
A generic term for any organ or surrogate device used to stabilize a patient before definitive transplantation of a matched organ.
Transplant Rejection happens when a person receives an organ from someone else during transplant surgery, that person's immune system may recognize that it is foreign. This is because the person's immune system detects that the antigens on the cells of the organ are different or not "matched." Mismatched organs, or organs that are not matched closely enough, can trigger a blood transfusion reaction or transplant rejection.
In Organ transport system the organs are placed in sterile containers, packaged in wet ice, and transported to the recipient's transplant center. Hearts and lungs must be transplanted within approximately four hours after being removed from the donor in transport system.
Commercialization of Organs in itself cannot be held as immoral. The  premier  and  essential  objection  to  the  sale  of  human  body  parts  on secular grounds is that commercialization would tend unavoidably to harm sellers.  More  specifically,  the  basic  concern  here  is  that  due  to  the  sup-posed inevitability of exploitation and coercion, the sale of human body parts cannot be contained in a just health care system. We will address this core  secular  argument  in  terms  of  its  two  separable,  primary  elements: exploitation and coercion.

Market Analysis

Importance and scope:
Organ transplantations save lives in patients affected by terminal organ failures and improve quality of life. Organ transplantations have gradually ameliorated in the last two decades and usually provide excellent results in children and young adults, and are increasingly challenged by the growing proportion of elderly transplant patients with comorbidities. Renal transplantation increases patient survival over dialysis, and lifesaving transplants are indispensable to treat patients with liver, heart, or lung irreversible diseases. Organ transplant programs activity has been steadily growing but is still far from global needs, with great differences among countries. Solid organ transplantations are essential for developed and mature health care systems. The factors driving this market include the advancements made in tissue engineering and organ transplantations. These transplantations help in survival of many patients as well as enhance the quality of life. The lack of availability of organs and high cost of transplantation are the limitations for the growth of this market. The increase in use of tissue engineering for generation of implants provides growth opportunity to this market.
Organ transplant immunosuppressant drugs market has accelerated the growth of rapid organ transplant by reducing the harmful side effects such as autoimmune diseases. These novel drug therapies are strategically analyzed in the report in order to provide comparative benefits. The report is also focusing on the regulatory issues and commercial mandate that are hindering the growth. Porter’s five forces model is strategically analyzed in the report to project current and future market scenarios. The value chain analysis of the organ transplant immunosuppressant drugs market is dealt strategically. Top wining strategies adopted by the key players competing in this market are critically analyzed through primaries.
Value of Organ Transplantation in Society:
Transplantation in number of procedures. The global and regional markets for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments - Organ Transplantation (Heart, Kidneys, Liver, Pancreas, and Lungs). The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
At least 79,950 kidney transplants done in 2014.
*Kidney transplants are done in 99 countries.
* 27,397 donations were reported from dead persons in 2014. Currently there are 77 countries worldwide with deceased donation programmes
* About 119,900 solid organs were transplanted worldwide in 2014, an increase of 1.8 per cent since 2013
*26,150 liver transplants were done worldwide in 2014. Liver transplants are performed in 74 countries
* 119,873 organs transplanted annually (2014)
* 27,397 actual deceased organ donors in 2014
* 13.6 transplants per hour done in 2014
* In 2012, the UAE did 19 kidney transplants from living donors and 28 in 2013 - Data from Global Observatory on Donation and Transplantation.
The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immune suppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure. Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives. The organ and tissue transplantation market in the U.S. is estimated at $11.7 billion in 2005 and is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010.The transplantation market is estimated at just under $5 billion in 2005 and is expanding at an AAGR of 4.8%.The fastest growing sector is small bowel (intestine) transplantation. Kidney and liver transplantation will account for 78% of the total in 2005.The U.S. tissue transplantation market totaled about $6.8 billion in 2005. It is projected to grow at an AAGR of 5.5%, to $8.9 billion in 2010.
Organ Transplants in New Zealand:
New Zealand has made gains in organ donation. A record number of deceased people gifted organs in New Zealand this year, continuing an upward trend in donation rates but overseas experts say only a national reform will reap the country big gains in donation rates. As of November 19, 63 people donated their organs, up from 61 in 2016 and 53 in 2015.
Dr James Judson, a medical specialist for Organ Donation New Zealand, said much of the increase in donations rates can be attributed to the quality improvement programme rolled out across the country's intensive care units since 2011. In 2016, New Zealand had 13 deceased organ donors per million population, compared to 20.8 in Australia and 21.4 in the United Kingdom.
Judson travelled to Geneva in September to attend the International Society for Organ Donation and Procurement's 14th congress and delivered the message New Zealand's deceased donor rates were tracking in the right direction. Organs can be donated after a patient is declared brain dead (DBD) or after circulatory death (DCD), after the heart has stopped.
New Zealand rates of DBD were almost the same as Australia and the UK. "We've seen this trend and for the first time it's statistically significant. We've done quite well in DBD."
New Zealand's DCD rates would increase as more health professionals identified it as a possibility and became more familiar and comfortable with the process. Since 2009, there has been a 104 per cent increase in deceased organ donors in Australia, up from 247 to 503 in 2016.
The state of Victoria led the country in 2016, with 140 deceased organ donors. Earlier this year, then health minister Jonathan Coleman released a national strategy aimed at increasing deceased donation and transplantation in New Zealand.
"There's been some modest funding for link nurses and funding to boost live kidney donation in New Zealand but New Zealand hasn't received the same amount of funding that Australia began to invest in 2009," she said. So it's a credit to James Judson and others working in New Zealand that New Zealand rates have increased.
"But if you want to significantly increase donation you have to put strategies and resources into it. And if you want to improve anything you have to pay people to make it their priority and that's what happened in Australia."
In 2016, New Zealand's DCD rate was 1.3 donors per million populations, compared to Australia at 5.3 and the UK at 8.9.
Organ Donation New Zealand (ODNZ) sincerely thanks all the families who agreed to organ and tissue donation in 2018. It is important to acknowledge and remember that all donors come out of human tragedy and that organ and tissue donation would not be possible without the generosity of families at a very difficult time.
In the past year, there were 73 donors who donated organs following death, enabling 215 recipients to receive kidney, liver, lung, heart or pancreas transplants. Many more people received tissue transplants (eye tissue, heart valves and skin) from these donors Of the 73 deceased donors, 61 were donors after brain death (DBD, where the brain is dead but the heart has not yet stopped), compared with 34 DBD donors in 2013 (a 79% increase over five years).  12 were donors after circulatory death (DCD, after the heart has stopped), compared with 2 DCD donors in 2014 (a 500% increase). There is the potential for a further increase in the number of DCD donations.
ODNZ has continued to provide training for ICU staff on the DCD process and in 2018 the first DCD lung donation was facilitated. Until recently DCD donation only included liver, kidneys and tissues.
Deceased organ donation in New Zealand:
The annual number of deceased organ donors in New Zealand has doubled over the last five years; from 36 in 2014 to 73 in 2018.
This two-year measure consists of four key elements that will improve organ and tissue donation rates:
• improving systems to allow better matching of available organs to potential transplant recipients.
• implementing the Donate Life Collaborative to improve organ and tissue donation clinical practice.
• enhancing online registration to increase the number of registrations on the New Zealand Organ Donor Register.
• extending the Supporting Leave for Living Organ Donors Program.
Why to attend???
The significance of human life and organs. Organ Transplantation is essential for us. Heart, Kidney, Liver, pancreas, and so many organs are Trans planted. This conference seek to bring all such Cardiologists, Therapists, Surgeons, Healthcare Agencies, Healthcare Professionals, Doctors, Registered Nurses and researcher or scientist, Noble Laureate, researcher, research scholar, students and people together who are involved in this field and provide them to discuss about their innovation, exchange ideas and interaction with each other.
Major Organ Donation Societies around the Globe:
WHO Global Observatory on Donation and Transplantation (GODT)
Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT)
Donation and Transplantation Institute (DTI)
International Society for Heart and Lung Transplantation (ISHLT)
International Society for Organ Donation and Procurement (ISODP)
International Transplant Nurses Society (ITNS)
Transplantation Society of Australia and New Zealand
Australia: Organ and Tissue Authority
Philippines: National Kidney and Transplant institute
Japan: Japan Organ Transplant Network
Malaysia: Malaysia Society of Transplantation
Singapore: National Organ Transplant Unit
Saudi Arabia: Saudi Centre for Organ Transplantation
Middle East Society for Organ Transplantation (MESOT)
Israel: ADI - National Transplant Center
European Society of Transplantation
Belgian Transplantation Society
Denmark: Dansk Transplantationsselskab
France: French Federation for Organ Donation
Germany: Deutsche Stiftung Organtransplantation (DSO)
Greece: Hellenic National Transplant Organization
Italy: Centro Nazionale Trapianti (CNT)
Netherlands: Nederlandse Transplantatie Vereniging
Poland: Poltransplant
Spain: Organización Nacional de Trasplantes (ONT)
United Kingdom: National Health Service Blood and Transplant
Brazil: Coordenaçao -Geral do Sistema Nacional de Transplantes
Mexico: Centro Nacional de Trasplantes (CENATRA)
Canadian Blood Services – Organ and Tissue Donation and Transplantation
American Society of Transplantation (AST)
Target Audience:
The target audience will be Cardiologists, Therapists, Surgeons, Healthcare Agencies, Healthcare Professionals, Doctors, Registered Nurses and researcher or scientist who are researching in Organ Donation and Transplantation Science.
Meet Your Target Market:
With members from around the world focused on learning about Surgeons, this is your single best opportunity to reach the largest assemblage of participants from the all Over the World. Conduct demonstrations, distribute information, meet with current, make a splash with a new product line, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Organ Donation and Transplantation Science are hallmarks of this conference.

To Collaborate Scientific Professionals around the World

Conference Date July 14-15, 2019

Speaker Opportunity

Supported By

Journal of Transplantation Technologies & Research Reconstructive Surgery & Anaplastology Medical Safety & Global Health

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by